Literature DB >> 32568598

The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets.

Caitlin T Di Paolo1,2, Eleftherios P Diamandis1,2,3, Ioannis Prassas2.   

Abstract

The skin is a vital organ of the human body, serving numerous protective and functional roles that are essential for survival. Residing in the epidermis are various epidermal proteases responsible for the establishment and regulation of barrier function. The human tissue kallikrein-related peptidase family conserves homeostasis of the skin barrier through their roles in desquamation, antimicrobial defense, innate immune response, and barrier maintenance. The activity of kallikreins is tightly regulated and dysregulation of kallikrein activity is seen to contribute to the formation of several inflammatory skin disorders. This review highlights the roles of kallikreins in skin homeostasis and pathologies. Due to their part in these skin disorders, inhibitors of the skin kallikreins have become attractive therapeutics. Over the past few years, both natural and synthetic inhibitors of several kallikreins have been identified and are undergoing further development as treatments to restore compromised barrier function. This review summarizes the kallikrein inhibitors under development for this purpose. These inhibitors remain promising therapeutics in cases of severe skin inflammation not well managed by current therapies.

Entities:  

Keywords:  Kallikrein; PAR; atopic dermatitis; epidermal proteases; epidermis; inflammation; inhibitor; psoriasis; rosacea; skin

Year:  2020        PMID: 32568598     DOI: 10.1080/10408363.2020.1775171

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  5 in total

Review 1.  Remodelling of the tumour microenvironment by the kallikrein-related peptidases.

Authors:  Srilakshmi Srinivasan; Thomas Kryza; Jyotsna Batra; Judith Clements
Journal:  Nat Rev Cancer       Date:  2022-01-31       Impact factor: 69.800

2.  A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.

Authors:  Jian-Kui Du; Qing Yu; Yu-Jian Liu; Shu-Fang Du; Li-Yang Huang; Dan-Hong Xu; Xin Ni; Xiao-Yan Zhu
Journal:  Theranostics       Date:  2021-02-20       Impact factor: 11.556

Review 3.  Adipokines in the Skin and in Dermatological Diseases.

Authors:  Dóra Kovács; Fruzsina Fazekas; Attila Oláh; Dániel Törőcsik
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

4.  Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma.

Authors:  Xiaokaiti Abuduhadeer; Xincai Xu; Kamali Aihesan; Maimaiti Yilihamu; Yanjun Zhao; Wenbin Zhang
Journal:  J Clin Lab Anal       Date:  2021-09-12       Impact factor: 2.352

Review 5.  Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases.

Authors:  Marcelo B Zani; Aquiles M Sant'Ana; Rafael C Tognato; Jair R Chagas; Luciano Puzer
Journal:  Front Med (Lausanne)       Date:  2022-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.